Exhibit II to Schedule 13G Joint Filing Agreement
Exhibit II
to
Schedule 13G
The undersigned persons agree and consent to the joint filing on their behalf of this Schedule 13G dated November 14, 2024 in connection with their beneficial ownership of Altimmune, Inc. Each of TAM UK International Holdings Limited, Threadneedle Holdings Limited, TAM UK Holdings Limited, Threadneedle Asset Management Holdings Limited, TC Financing Limited, Threadneedle Asset Management Limited and Threadneedle Investment Services Limited authorizes Ameriprise Financial, Inc. to execute the Schedule 13G to which this Exhibit is attached and make any necessary amendments thereto.
| Ameriprise Financial, Inc. | ||
| By: | /s/ Xxxxxxx X. Xxxxxx | |
| Name: | Xxxxxxx X. Xxxxxx | |
| Title: | Senior Vice President, North America Head of Operations & Investor Services | |
| TAM UK International Holdings Limited Threadneedle Holdings Limited TAM UK Holdings Limited Threadneedle Asset Management Holdings Limited TC Financing Ltd Threadneedle Asset Management Limited Threadneedle Investment Services Limited | ||
| By Columbia Management Investment Advisers, LLC, as Attorney in Fact | ||
| By: | /s/ Xxxxxxx X. Xxxxxx | |
| Name: | Xxxxxxx X. Xxxxxx | |
| Title: | Senior Vice President, North America Head of Operations & Investor Services |
